Key facts
- Our Belux head office is located in Braine-l'Alleud
- BMS has been active in Belgium and Luxembourg for more than 40 years
- Every day, our people work together to make a difference in the lives of patients suffering from serious diseases
- Through more than 95 active clinical trials with more than 800 patients, we ensure that Belgian and Luxembourg patients have access to the most innovative new medicines
- We continue to invest and develop our pipeline, and we are the leader in a number of new indications
Historical overview of reimbursed medicines in Belgium
BMS Worldwide
Update 2022
Chief Executive Officer:
Headquarters:
New York City
Business:
Biopharmaceuticals
Website:
NYSE Listing:
BMY
Net Global Sales:
$46.0 billion in 2021
R&D Investment:
$11.14 billion which included the discovery and development of new medicines for patients
Principal Locations:
BMS in Belgium
Update 2022
General Manager:
Sally Ann McNab
Local Headquarters:
Parc de l’Alliance
Avenue de Finlande 4
1420 Braine-l’Alleud
Avenue de Finlande 4
1420 Braine-l’Alleud
Key Therapeutic Areas:
Oncology
Hematology
Cardiovascular
Immunology